MYC and neoplasm: In addition, our in vivo experiments showed no significant reduction in tumor outgrowth in response to SUMOylation inhibition as single compound therapy, whereas literature suggest that SUMO abolishment by genetic knock down of the E1 enzyme does reduce tumor outgrowth in MYC dependent tumors [26, 27].